Results 271 to 280 of about 73,620 (322)

A new era in myeloma: the advent of chimeric antigen receptor‐T (CAR‐T) cells and bispecific antibodies

open access: yesInternal Medicine Journal, EarlyView.
Abstract T‐cell re‐directional therapies, including chimeric antigen receptor (CAR)‐T cell and bispecific antibodies (BsA), have transformed the treatment landscape to benefit patients with multiple myeloma. A number of these novel therapies has been approved internationally, with CAR‐T therapy recently approved in Australia.
P. Joy Ho, Eric W. Li
wiley   +1 more source

Combining SKY92 gene expression profiling and FISH (according to R2-ISS) defines ultra-high-risk Multiple Myeloma. [PDF]

open access: yesHemasphere
Zhou X   +21 more
europepmc   +1 more source

Molecular techniques in haematopathology: what and how? [PDF]

open access: yesHistopathology
Chatterjee G   +4 more
europepmc   +1 more source

Cytogenetics in retinoblastomas

open access: yesIndian Journal of Ophthalmology, 1975
Rao K, Rao C, Radhakrishna G
doaj  

Cave-dwelling bats of Carajás National Forest: New cytogenetic data of threatened species. [PDF]

open access: yesEcol Evol
da Silva JB   +6 more
europepmc   +1 more source

CAT rs1001179 Single Nucleotide Polymorphism Identifies an Aggressive Clinical Behavior in Chronic Lymphocytic Leukemia. [PDF]

open access: yesHematol Oncol
Galasso M   +17 more
europepmc   +1 more source

Detection of a Lymphoproliferative Disorder With Suspected Scattergram Analysis Using the Mindray BC‐6800 Plus Automated Hematology Analyzer: A Case Report

open access: yes
International Journal of Laboratory Hematology, EarlyView.
Sara Sacchetti   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy